COST-EFFECTIVENESS IN THE TREATMENT OF ADVANCED SOLID TUMORS

被引:4
作者
RUBENS, RD
机构
关键词
D O I
10.1016/S0959-8049(05)80162-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
When the treatment of advanced cancer is palliative in intent, evaluation of quality of life is of paramount importance in judging the effectiveness of treatment. The balance between adverse effects (costs) and benefits has been particularly difficult to determine with cytotoxic drugs. An approach to this problem using medical audit is described. It has been found to be a reliable method which has demonstrated a highly significant correlation between achievement of objective regression and acquisition of benefit. The method is now undergoing corroboration by a prospective study.
引用
收藏
页码:604 / 605
页数:2
相关论文
共 3 条
[1]   ASSESSMENT OF RESPONSE TO THERAPY IN ADVANCED BREAST-CANCER - PROJECT OF PROGRAM ON CLINICAL ONCOLOGY OF "INTERNATIONAL-UNION-AGAINST-CANCER, GENEVA, SWITZERLAND [J].
HAYWARD, JL ;
RUBENS, RD ;
CARBONE, PP ;
HEUSON, JC ;
KUMAOKA, S ;
SEGALOFF, A .
BRITISH JOURNAL OF CANCER, 1977, 35 (03) :292-298
[2]   LIVER METASTASES FROM BREAST-CANCER - THE RELATIONSHIP BETWEEN CLINICAL, BIOCHEMICAL AND PATHOLOGICAL FEATURES AND SURVIVAL [J].
OREILLY, SM ;
RICHARDS, MA ;
RUBENS, RD .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (05) :574-577
[3]   APPROPRIATE CHEMOTHERAPY FOR PALLIATING ADVANCED CANCER [J].
RUBENS, RD ;
TOWLSON, KE ;
RAMIREZ, AJ ;
COLTART, S ;
SLEVIN, ML ;
TERRELL, C ;
TIMOTHY, AR .
BRITISH MEDICAL JOURNAL, 1992, 304 (6818) :35-40